PMID- 14562045 OWN - NLM STAT- MEDLINE DCOM- 20031126 LR - 20091119 IS - 0950-9232 (Print) IS - 0950-9232 (Linking) VI - 22 IP - 46 DP - 2003 Oct 16 TI - An increase in the expression and total activity of endogenous p60(c-Src) in several factor-independent mutants of a human GM-CSF-dependent leukemia cell line (TF-1). PG - 7170-80 AB - Growth factor independence of hematopoietic cells can be induced by ectopic expression of a variety of oncogenes encoding receptor or cytoplasmic tyrosine kinases. To examine whether the activation of tyrosine kinases occurs in factor-independent mutants in vivo, the tyrosine-phosphorylated proteins from 14 factor-independent mutants of a GM-CSF-dependent cell line (TF-1) were analysed. These mutants did not secrete any growth-stimulating activity for TF-1 cells, suggesting that activation of intracellular signaling rather than an autocrine stimulation by secreted growth factors is responsible for their factor-independent growth. In 11 out of 14 GM-CSF-independent mutants analysed, a constitutively tyrosine-phosphorylated protein of 60 kDa was detected, which was subsequently identified as p60(c-Src). The kinase activity of p60(c-Src) was increased up to 12-fold in these mutants, which was at least in part due to overexpression of the c-src gene on the RNA and protein level. The Src substrate Sam68 showed an increased phosphorylation in mutants with high Src activity, suggesting that p60(c-Src) triggers downstream signaling in these cells. Treatment of the factor-independent mutants with the Src kinase inhibitor PP2 resulted in a reduced proliferation, demonstrating that Src kinases are essential for these cells for maximal proliferation. Further analysis of factor-independent mutants with low or undetectable Src activity revealed a constitutive phosphorylation of the common beta chain of the GM-CSF receptor and STAT5. Our data indicate an increase in the expression and total activity of endogenous p60(c-Src) in several GM-CSF-independent TF-1 mutants, further underlining the role of Src in the process of autonomous growth of hematopoietic cells. FAU - Horn, Stefan AU - Horn S AD - Zentrum fur Experimentelle Medizin, Institut fur Biochemie und Molekularbiologie I, Zellulare Signaltransduktion, Universitatsklinikum Hamburg-Eppendorf, Martinistr 52, D-20246 Hamburg, Germany. FAU - Meyer, Johann AU - Meyer J FAU - Stocking, Carol AU - Stocking C FAU - Ostertag, Wolfram AU - Ostertag W FAU - Jucker, Manfred AU - Jucker M LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - England TA - Oncogene JT - Oncogene JID - 8711562 RN - 0 (DNA Primers) RN - 83869-56-1 (Granulocyte-Macrophage Colony-Stimulating Factor) RN - EC 2.7.10.2 (Proto-Oncogene Proteins pp60(c-src)) SB - IM MH - Base Sequence MH - Cell Division/drug effects MH - Clone Cells MH - DNA Primers MH - Gene Expression Regulation, Enzymologic/drug effects MH - Gene Expression Regulation, Neoplastic/*drug effects MH - Granulocyte-Macrophage Colony-Stimulating Factor/*pharmacology MH - Humans MH - Leukemia, Erythroblastic, Acute MH - Mutagenesis MH - Phosphorylation MH - Proto-Oncogene Proteins pp60(c-src)/*genetics/*metabolism MH - Reverse Transcriptase Polymerase Chain Reaction MH - Tumor Cells, Cultured EDAT- 2003/10/17 05:00 MHDA- 2003/12/03 05:00 CRDT- 2003/10/17 05:00 PHST- 2003/10/17 05:00 [pubmed] PHST- 2003/12/03 05:00 [medline] PHST- 2003/10/17 05:00 [entrez] AID - 1206856 [pii] AID - 10.1038/sj.onc.1206856 [doi] PST - ppublish SO - Oncogene. 2003 Oct 16;22(46):7170-80. doi: 10.1038/sj.onc.1206856.